Category:
Preclinical Research Services
CAS NO:
N/A
Standard:
ChP,
Indisetron is a selective 5-HT3 receptor antagonist primarily developed for the management of chemotherapy-induced nausea and vomiting (CINV). Synthesized via specific heterocyclic coupling, its molecular formula is C24H29N3O2 with CAS No. 156087-56-4.
Contraindicated in patients with known hypersensitivity to indoles. Strictly store below 25°C in a dry, dark environment to prevent hydrolysis. Monitor QT interval prolongation risks during concurrent use with other antiemetics.